Boston, MA, United States of America

Sarah Davis

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 16(Granted Patents)

Forward Citations (Not Self Cited) = 2(Sep 21, 2024)

Location History:

  • Wellesley, MA (US) (2023)
  • Boston, MA (US) (2022 - 2024)


Years Active: 2022-2025

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Innovations and Contributions of Inventor Sarah Davis

Introduction

Sarah Davis, an accomplished inventor based in Boston, MA, has made significant contributions to the field of biotechnology with her innovative patents. With a total of three patents to her name, her work has paved the way for advancements in medical treatments, particularly in the context of emerging health challenges.

Latest Patents

Among her most recent patents is the development of oligonucleotides for SARS-CoV-2 modulation. This breakthrough relates to novel targeting sequences designed specifically for combating SARS-CoV-2 infections. Alongside this, she has also created optimized anti-FLT1 oligonucleotide compounds aimed at treating preeclampsia and other angiogenic disorders. This patent encompasses methods for utilizing these novel oligonucleotides in the treatment of various angiogenic disorders, improving patient outcomes and expanding therapeutic options.

Career Highlights

Sarah has been associated with prestigious institutions such as the University of Massachusetts and Beth Israel Deaconess Medical Center. Her work in these organizations has not only facilitated her research but has also opened avenues for collaboration with leading experts in her field.

Collaborations

Throughout her career, Sarah has worked closely with noteworthy colleagues such as Anastasia Khvorova and Annabelle Biscans. Together, they have contributed to innovative projects and research efforts that aim to advance medical knowledge and provide effective solutions for complex health issues.

Conclusion

In summary, Sarah Davis stands out as an influential inventor with a commendable track record in the biotechnology sector. Her patents reflect her dedication to addressing critical health challenges and showcase her commitment to innovation. As she continues to collaborate and develop novel solutions, her impact on the field will undoubtedly resonate for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…